CNO Financial Delivers Record Growth, Sets Upbeat Outlook
CNO Financial Group ((CNO)) has held its Q4 earnings call. Read on for the main highlights of the call.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CNO Financial Rides Record Growth Despite Emerging Headwinds
CNO Financial Group’s latest earnings call struck a decidedly upbeat tone, underscored by record sales, expanding product margins, and strong investment yields that translated into better profitability and robust capital returns. Management openly acknowledged macroeconomic uncertainty, pressure in Medicare Advantage, and some non-recurring investment income benefits, but repeatedly emphasized that the breadth and consistency of operating momentum, disciplined capital deployment, and a clear multi‑year plan leave the company on solid footing heading into the next phase of its strategy.
Record Production and Sales Growth
CNO delivered record total new annualized premium (NAP), up 15% for the full year, marking its 14th consecutive quarter of sales growth. Management highlighted multiple production records across divisions and product lines, underscoring that growth was not driven by a single hot product but by broad-based demand across the franchise. That streak of quarterly gains stands out in a choppy macro backdrop and signals both successful distribution execution and the resilience of CNO’s middle-market customer focus.
Consumer Division: Multi-Product Momentum
The Consumer division turned in a particularly strong year with double‑digit growth across several lines. Life insurance NAP rose 10%, driven in part by a 20% surge in direct-to-consumer (D2C) life sales, where more than 70% of leads now come from non-TV channels—evidence that digital and alternative marketing investments are paying off. Total health NAP climbed 22%, with supplemental health up 15% and long-term care up 4%. Medicare Supplement was a standout, with NAP up 49% for the year and an eye‑catching 92% in the quarter, showing CNO’s ability to capture opportunity even as broader Medicare markets face pressure. Annuity collected premiums increased 9% year over year (3% in Q4), pushing in‑force annuity values above $13 billion, up 7%. Meanwhile, brokerage and advisory client assets jumped 24% to more than $5 billion, bolstering the company’s fee-based, asset‑gathering capabilities.
Worksite Division: Best Production Year Ever
CNO’s Worksite division reported its best production year on record, with full‑year insurance sales up 15% and fourth‑quarter insurance sales up 13%. Life sales surged 36%, hospital indemnity grew 41%, and accident sales advanced 11%, demonstrating strong employer and employee demand across key protection categories. Geographic expansion added 11% to NAP growth, and new group clients contributed a 23% increase in NAP, showing that CNO is successfully expanding its footprint and deepening penetration in the workplace benefits channel. This performance positions Worksite as a key growth engine and an increasingly important counterbalance to consumer-focused lines.
Profitability and Operating Metrics Move Higher
Profitability improved in tandem with top‑line growth. Operating return on equity (excluding significant items) rose to 11.4%, up from a roughly 10% run rate in 2024, which management described as one of the company’s best operating performances on record. Operating earnings per diluted share reached $4.40, and full‑year operating EPS excluding significant items of $4.02 came in above guidance ranges. This step‑up in earnings quality and ROE suggests that CNO is not merely selling more but doing so at attractive margins, a key point of focus for investors watching returns on capital.
Expense Discipline, Tax Benefits and Efficiency
Cost control and tax efficiency added another layer of support to earnings. The full-year expense ratio (excluding significant items) was 18.9%, better than the low end of CNO’s original guidance. This indicates the company is gaining scale and operating leverage even while investing in growth and technology. The effective tax rate on operating income landed at 20.6%, below the previously guided 22.0–22.5% range, providing a tailwind to bottom-line results and highlighting some structural benefits in CNO’s tax profile.
Capital Returns and Shareholder-Friendly Actions
CNO leaned into capital returns as its financial position strengthened. The company returned $386 million to shareholders, up 11% versus 2024, with $320 million deployed in share repurchases—an increase of 14% year over year. About $60 million of those buybacks occurred in the fourth quarter, helping reduce the weighted average diluted share count by roughly 8%. This aggressive but targeted repurchase activity signals management’s confidence in the intrinsic value of the stock and enhances per‑share growth metrics for investors.
Investment Performance and Yield Tailwinds
On the investment side, CNO continued to benefit from higher interest rates and disciplined portfolio management. New money rates exceeded 6% for the 12th consecutive quarter, with the latest new money rate at 6.11%. Allocated net investment income grew 6% for the year, supported by record invested assets of $31 billion, 97% of which are investment grade with an average rating of single‑A. The company deployed $1.6 billion into new investments in the quarter at an average A rating and a 6‑year duration, balancing yield enhancement with prudent credit and duration risk. These dynamics support both current earnings and long‑term liability management.
Robust Capital and Liquidity Underpin Strategy
CNO’s balance sheet remains a key strength. The consolidated risk-based capital (RBC) ratio stood at 380%, comfortably within the 360%–390% target range, giving management flexibility to pursue growth and capital returns. Holding company liquidity ended the year at $351 million, well above the stated minimum of $150 million, while the debt‑to‑total‑capital ratio remained within the 25%–28% target band. This solid capital and liquidity posture underpins the company’s ability to weather macro volatility and continue funding its multi‑year investment and modernization initiatives.
Clear 2026 Guidance and Multi-Year Investment Plan
Looking ahead, CNO provided detailed 2026 guidance and reaffirmed its multi-year investment roadmap. The company is targeting operating EPS of $4.25–$4.45, implying about 8% growth at the midpoint versus 2025, alongside an expense ratio of 18.8%–19.2%, which is expected to be seasonally higher in the first quarter. Fee income is projected at roughly $30 million, front‑loaded with about one-third in Q1 and minimal contributions in Q2 and Q3 before picking up again in Q4. The effective tax rate is guided to ~22.5%, and free cash flow is forecast at $200–$250 million, already net of planned technology modernization spending. Management reiterated its objective to lift run-rate operating ROE by 200 basis points between 2024 and 2027—from around 10% toward roughly 12%—and reaffirmed capital and liquidity targets, including an RBC range of 360%–390%, minimum holding-company liquidity of $150 million, and a debt‑to‑capital ratio of 25%–28%. The $170 million three‑year tech modernization program remains on track, with $20 million spent in 2025 and around $75 million slated for 2026.
Medicare Advantage Pressure and Market Dynamics
Despite the strong Medicare Supplement results, CNO faced headwinds in Medicare Advantage (MA). MA policies sold declined 3% for the year, as carriers pared back plans and benefits in response to industry and regulatory pressures. Management cautioned that this environment could continue to pressure distribution fees and potentially increase policy churn. While not a dominant part of the portfolio, the MA softness is a reminder that parts of CNO’s health franchise are exposed to broader payer decisions and policy shifts.
Macroeconomic Uncertainty and Discretionary Product Risk
Management repeatedly flagged macroeconomic uncertainty—particularly a weaker job market and potential layoffs—as a risk factor that could affect demand for more discretionary products like annuities, life insurance, and long-term care. While a softer labor market might improve recruiting conditions for agents, it can weigh on consumer confidence and household budgets, leading some customers to delay or reduce purchases. CNO framed this as a visibility issue rather than a current crisis, but it remains a watchpoint for investors given the company’s growth in these categories.
Quarterly Annuity Growth Moderation
Annuities illustrated the macro sensitivity in real time. While full-year annuity collected premiums rose a healthy 9%, fourth‑quarter growth slowed to 3%, hinting at some near‑term caution among consumers facing economic uncertainty and competing savings options. Management did not signal any structural change in the annuity franchise, but the quarterly slowdown underscores how quickly sentiment can shift in interest rate–sensitive, discretionary savings products.
Volatility in Unallocated Investment Income
CNO also highlighted some noise in unallocated net investment income (NII). During the quarter, unallocated NII benefited from a $12 million special dividend and income from variable alternative investments. Management cautioned that these items are not necessarily repeatable and can cause quarter‑to‑quarter volatility in reported NII, even if core allocated investment income trends remain solid. Investors tracking earnings quality will need to distinguish between these episodic gains and underlying run‑rate yield performance.
Reinsurance Strategy and Conservative Assumptions
The company completed a second reinsurance treaty in the fourth quarter, further optimizing capital and risk transfer, but chose to keep its 2026 guidance conservative by not assuming additional Bermuda treaties beyond the two already in place. Management tied this stance to the regulatory cadence and approval process around such deals. This approach tempers near-term upside from reinsurance but reduces execution and regulatory risk, aligning with the broader theme of disciplined capital management.
Worksite Fee Services Exit and Operational Transition
CNO is in the process of exiting its Worksite fee services business, with the transition expected to be largely complete in the first half of 2026. Management indicated that the strategic benefits of the exit—simplification and focus on core insurance offerings—are already becoming visible. However, they also acknowledged near‑term execution risk as systems, clients, and revenue streams are realigned. For investors, this move represents a tactical pruning of non-core activities in favor of higher‑return, more scalable lines of business.
In sum, CNO Financial Group’s earnings call painted a picture of a company delivering record growth, expanding profitability, and robust capital returns while carefully navigating industry pressures and macro uncertainty. Strong execution in both Consumer and Worksite divisions, coupled with disciplined investment management and a clearly articulated 2026 roadmap, supports an overall positive outlook. Risks from Medicare Advantage, economic softness, and non-recurring investment income items bear watching, but the underlying momentum and balance sheet strength suggest CNO remains well-positioned for continued value creation for shareholders.
